Paul Tudor Jones Royalty Pharma PLC Transaction History

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 642,736 shares of RPRX stock, worth $23.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

642,736

Previous 727,736 11.68%

Holding current value

$23.4 Million

Previous $22.7 Million 2.22%

% of portfolio

0.05%

Previous 0.08%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$30.85 - $36.14 $2.62 Million - $3.07 Million	-85,000 Reduced 11.68%	642,736 $23.2 Million
Q1 2025 May 15, 2025	SELL	$25.75 - $33.86 $187,743 - $246,873	-7,291 Reduced 0.99%	727,736 $22.7 Million
Q4 2024 Feb 14, 2025	BUY	$24.28 - $28.39 $5.49 Million - $6.42 Million	226,274 Added 44.48%	735,027 $18.8 Million
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $5.03 Million - $5.74 Million	196,253 Added 62.8%	508,753 $14.4 Million
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $7.78 Million - $8.86 Million	296,452 Added 1847.28%	312,500 $8.24 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $1.5 Million - $1.72 Million	-54,742 Reduced 77.33%	16,048 $487,000
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $3.62 Million - $4.03 Million	-138,083 Reduced 66.11%	70,790 $1.99 Million
Q3 2023 Nov 15, 2023	BUY	$26.26 - $31.38 $3.88 Million - $4.64 Million	147,933 Added 242.75%	208,873 $5.67 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $1.8 Million - $2.23 Million	60,940 New	60,940 $1.87 Million

Others Institutions Holding RPRX

# of Institutions

497

Shares Held

307M

Call Options Held

1.99M

Put Options Held

384K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.9B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account